-
Je něco špatně v tomto záznamu ?
Utility of a guiding catheter for conduction system pacing: An early multicenter experience
J. De Pooter, A. Bulava, D. Gras, S. Timmer, G. Chin-Pang Chan, N. Clementy, RK. Pathak, S. Healy, U. Lüsebrink, F. Zanon
Status neindexováno Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2020
PubMed Central
od 2020
ROAD: Directory of Open Access Scholarly Resources
od 2020
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Conduction system pacing (CSP), either as His bundle pacing (HBP) or as left bundle branch area pacing (LBBAP), may be superior to right ventricular apical or septal pacing. OBJECTIVE: The study sought to present acute results for a new guiding catheter (Biotronik Selectra 3D) designed for CSP implantations of a retractable screw-in lead (Biotronik Solia S). METHODS: The primary endpoint of the prospective, international nonrandomized BIO|MASTER.Selectra 3D study was freedom from catheter-related serious adverse device effects (SADEs) within 1 week of lead implantation. RESULTS: Of 157 enrolled patients, CSP was achieved in 147 (93.6%) patients. No SADEs occurred within 7 days. LBBAP was achieved in 82 patients (45 as crossover from an HBP attempt) and HBP in 65 (44.2%) patients. In centers considering both HBP and LBBAP, the CSP implantation success approached 99%. Successful CSP implantations lasted on average ∼50 minutes (fluoroscopy ∼6 minutes). Most procedures (87.9%) needed only 1 catheter, even after switch from HBP to LBBAP. The catheter's handling was rated largely positive. In patients without bundle branch block, mean QRS duration increased from 106 ms (intrinsic) to 122 ms (CSP) (P = .001). In patients with bundle branch block, mean QRS duration decreased from 151 ms (intrinsic) to 137 ms (CSP) (P = .004). CONCLUSION: The Selectra 3D catheter is a valuable tool for HBP and LBBAP implantations of the stylet-supported pacemaker leads. When implanters considered both HBP and LBBAP, the success rate was ∼99%. Flexibility to change between different approaches may be advisable in heterogeneous and challenging areas, such as CSP implantations.
Centre Hospitalier Régional Universitaire de Tours Cardiology Chambray lès Tours France
Hôpital Privé du Confluent Cardiology Nantes France
Monash Medical Centre Cardiology Melbourne Victoria Australia
Noordwest Ziekenhuisgroep Cardiology Alkmaar the Netherlands
Prince of Wales Hospital Cardiology Hong Kong
Santa Maria della Misericordia Arrhythmia and Electrophysiology Unit Rovigo Italy
Universitätsklinikum Gießen und Marburg Kardiologie Marburg Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006098
- 003
- CZ-PrNML
- 005
- 20240412130933.0
- 007
- ta
- 008
- 240405s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.hroo.2023.11.017 $2 doi
- 035 __
- $a (PubMed)38312208
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a De Pooter, Jan $u University Hospital Ghent, Ghent, Belgium
- 245 10
- $a Utility of a guiding catheter for conduction system pacing: An early multicenter experience / $c J. De Pooter, A. Bulava, D. Gras, S. Timmer, G. Chin-Pang Chan, N. Clementy, RK. Pathak, S. Healy, U. Lüsebrink, F. Zanon
- 520 9_
- $a BACKGROUND: Conduction system pacing (CSP), either as His bundle pacing (HBP) or as left bundle branch area pacing (LBBAP), may be superior to right ventricular apical or septal pacing. OBJECTIVE: The study sought to present acute results for a new guiding catheter (Biotronik Selectra 3D) designed for CSP implantations of a retractable screw-in lead (Biotronik Solia S). METHODS: The primary endpoint of the prospective, international nonrandomized BIO|MASTER.Selectra 3D study was freedom from catheter-related serious adverse device effects (SADEs) within 1 week of lead implantation. RESULTS: Of 157 enrolled patients, CSP was achieved in 147 (93.6%) patients. No SADEs occurred within 7 days. LBBAP was achieved in 82 patients (45 as crossover from an HBP attempt) and HBP in 65 (44.2%) patients. In centers considering both HBP and LBBAP, the CSP implantation success approached 99%. Successful CSP implantations lasted on average ∼50 minutes (fluoroscopy ∼6 minutes). Most procedures (87.9%) needed only 1 catheter, even after switch from HBP to LBBAP. The catheter's handling was rated largely positive. In patients without bundle branch block, mean QRS duration increased from 106 ms (intrinsic) to 122 ms (CSP) (P = .001). In patients with bundle branch block, mean QRS duration decreased from 151 ms (intrinsic) to 137 ms (CSP) (P = .004). CONCLUSION: The Selectra 3D catheter is a valuable tool for HBP and LBBAP implantations of the stylet-supported pacemaker leads. When implanters considered both HBP and LBBAP, the success rate was ∼99%. Flexibility to change between different approaches may be advisable in heterogeneous and challenging areas, such as CSP implantations.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bulava, Alan $u České Budějovice Hospital, Faculty of Health and Social Sciences, Cardiology, University of South Bohemia, České Budějovice, Czech Republic
- 700 1_
- $a Gras, Daniel $u Hôpital Privé du Confluent, Cardiology, Nantes, France
- 700 1_
- $a Timmer, Stefan $u Noordwest Ziekenhuisgroep, Cardiology, Alkmaar, the Netherlands
- 700 1_
- $a Chin-Pang Chan, Gary $u Prince of Wales Hospital, Cardiology, Hong Kong
- 700 1_
- $a Clementy, Nicolas $u Centre Hospitalier Régional Universitaire de Tours, Cardiology, Chambray-lès-Tours, France
- 700 1_
- $a Pathak, Rajeev K $u Canberra Heart Rhythm, Australian National University, Cardiology, Garran, Australian Capital Territory, Australia
- 700 1_
- $a Healy, Stewart $u Monash Medical Centre, Cardiology, Melbourne, Victoria, Australia
- 700 1_
- $a Lüsebrink, Ulrich $u Universitätsklinikum Gießen und Marburg, Kardiologie, Marburg, Germany
- 700 1_
- $a Zanon, Francesco $u Santa Maria della Misericordia, Arrhythmia and Electrophysiology Unit, Rovigo, Italy
- 773 0_
- $w MED00209104 $t Heart rhythm O2 $x 2666-5018 $g Roč. 5, č. 1 (2024), s. 8-16
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38312208 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240405 $b ABA008
- 991 __
- $a 20240412130926 $b ABA008
- 999 __
- $a ok $b bmc $g 2076125 $s 1215860
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 5 $c 1 $d 8-16 $e 20231202 $i 2666-5018 $m Heart rhythm O2 $n Heart Rhythm O2 $x MED00209104
- LZP __
- $a Pubmed-20240405